TSE:MFC

Manulife Financial (MFC.TO)

60.69
+0.02 (0.03%)
as of Jul 23, 2026, 8:00:00 pm Market Open.
1632 watching
0
Investor Insights
star iconJul 23, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has garnered mixed perspectives from various analysts, reflecting both its potential and current market position. While many experts acknowledge MFC's solid dividend yield and growth prospects, particularly in Asia, concerns about valuation and market conditions persist. The stock appears to be trading around 2x book value and has shown slow but steady growth, attracting attention from those looking for income rather than explosive growth. The consensus among experts is to proceed with caution and consider market pullbacks for optimal entry points, though some view the stock as a good long-term hold due to its stable dividend and cash flow. Overall, while there are positive signs, such as asset management improvements and capital growth, analysts advise careful monitoring given the mixed signals surrounding the broader financial sector's performance.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
SLF
COMMENT
Feels there is valuation support at these levels.
DON'T BUY
Not a big fan of this. Likes companies that do well in a tough environment and will do well going forward. Due to product mixes they were in a tough spot. Economy has challenges ahead and this would be one of the first that has to come back to the market again.
TOP PICK
If you are coming into it now, the balance sheet is that much better. Now they can go on and make acquisitions. They are one of the leaders in Asia. Cleaned up their balance sheet. They are still getting priced at levels that are somewhat irrational. Expects 30% return over the next two years.
DON'T BUY
Announcement of the new equity issue caught everybody by surprise and he thinks they will have a tough slog and they may have to reduce the price to get rid of the shares. Thinks the stock will be a dead issue for a while. Longer-term they have good assets. Prefers the banks.
HOLD
Announced a $2.5 billion share issue, which caught everybody by surprise. Hopes that they will use this for good acquisitions. Fundamentally it is worth more than $19 a share and expects it to trend upwards.
WATCH
Prefers Great West (GWO-T) because of their yield. This one and Sun Life (SLF-T) are more levered to the stock market. Likes their growth opportunities in China once they get their new team in place. They cut the dividend and are still smarting from this.
BUY
3rd quarter had a lot of charges and write-downs but the earnings power is still there.
COMMENT
Stock has broken below what should have been its support. If you own, use a $19 stoploss because if that amount triggers you are looking at $12 again.
COMMENT
Bought half a position. A “show me” story. He will watch, look at the earnings and if it appeals to him he will add to his position otherwise will sell.
DON'T BUY
$26 stock price is not too far-fetched if we get the US consumer coming back and there is economic growth in the developed world and there is continued recovery. Extremely exposed to what happens in the equity markets.
PARTIAL SELL
Problem with the lifecos in that they have a fair amount of business being done in the equity market through mutual fund sales. If equity markets come under pressure this will hit their earnings. He is lessening his holdings.
BUY
Lifecos are down basically because the market is down because of credit and stock market concerns. If you have any kind of time horizon you can't go wrong.
DON'T BUY
Wants to talk people out of the insurance sector. Would rather be in bank stocks.
DON'T BUY
This is a leveraged call on the stock market. If you are bullish on the stock market, you can stick with this one. If you are concerned, as he is, then you shouldn't go into this. Just a little bit shy of its Fair Market Value.
PAST TOP PICK
(Top Pick Nov 3/08, Down 9.86%) Reduced holdings because of the disappointment.
Showing 1,561 to 1,575 of 2,283 entries